Cedars-Sinai and Torrance Memorial Mark Four Years of Affiliation | Torrance Memorial

Published on March 25, 2022

Cedars-Sinai and Torrance Memorial Mark Four Years of Affiliation

Heart, stroke and cancer patients discuss how the unique collaboration fostered healing

Torrance Memorial Medical Center

Written by Christina Elston

This year marks the fourth anniversary of the affiliation between Torrance Memorial and Cedars-Sinai, a partnership forged to provide coordination of leading-edge healthcare and services to patients throughout greater Los Angeles.

“Our affiliation with Cedars-Sinai has worked out remarkably well and exceeded our initial expectations. By enabling both institutions to continue the unique relationships both have within the communities they serve while working together to coordinate world-class care, the South Bay community has benefited greatly,” President, CEO Craig Leach says.

The collaboration continues to provide Torrance Memorial patients with convenient local access to treatments in cancer, heart disease and brain disorders, all backed by an academic-level medical institution and making a profound difference in the lives of many over the years.

Susan Sestich

Susan and Mike Sestich walking Rosie

Today Susan Sestich is happily planning her daughter’s August wedding. But nearly two years ago, she suffered a massive stroke that almost ended her life.

When Sestich collapsed at home and couldn’t move, her husband called 911 and 

insisted paramedics transport her to Torrance Memorial, a Comprehensive Stroke Center that partners with a telestroke team at Cedars-Sinai.

“If a clinician at Torrance Memorial believes one of their patients might be having an acute stroke, they activate their emergency stroke system,” 

says Konrad Schlick, MD, assistant professor of neurology and director of the Vascular Neurology Fellowship Program at Cedars-Sinai. “We jump on camera to see the patient and rapidly make an assessment.”

Dr. Schlick, who was on call when Sestich was brought in, saw there was no blood flow on one side of her brain and she needed immediate treatment. He contacted George So, MD, an interventional radiologist at Torrance Memorial. “Her kind of stroke is the worst type we treat,” So says, “but our team is prepared for this kind of patient.”

Sestich was given medication to dissolve the blood clots in her brain, and Dr. So used a tiny catheter guided through an artery in Sestich’s groin to remove those that remained. Three days later, she was discharged from the hospital with very few after-effects.

“I can drive. I can ride a roller coaster. I was in Hawaii with my daughter and my son-in-law-to-be when he proposed,” says Sestich. “I get to live my life fully, and I’m so lucky to do it.”

Kristen Enomoto

Kristen Enomoto is celebrating her defeat of stage 3 breast cancer with the help of a Cedars-Sinai cancer clinical trial combined with treatment at the Torrance Memorial Hunt Cancer Institute. 

A year ago, an ultrasound follow-up to a routine mammogram detected two noncancerous cysts in Enomoto’s left breast. Fortunately, Enomoto had been experiencing discomfort under her left arm and asked the technician to check that area as well.

The ultrasound and a biopsy confirmed Enomoto had HER2-positive breast cancer that had spread to multiple lymph nodes. HER2, or human epidermal growth factor receptor 2, is a protein that promotes the growth of cancer cells.

Enomoto was facing 5½ months of chemotherapy, but Torrance Memorial breast cancer specialist David Chan, MD, suggested Enomoto enroll in a Cedars-Sinai clinical trial that let her complete chemotherapy in just three months.

In the study, Reva Basho, MD, codirector of the Women’s Cancer Program and assistant professor of medicine at Cedars-Sinai, is testing a treatment plan that increases the body’s immune response against HER2-positive breast cancer with the addition of a checkpoint inhibitor.

“The goal is to engage the immune system to allow us to de-escalate the amount of chemotherapy that needs to be given to patients with curable cancers while improving their long-term outcomes,” Dr. Basho said.

After 12 weeks of treatment, Enomoto had a mastectomy, and test results showed no active cancer remaining.

“We couldn’t prescribe this therapy outside of a clinical trial,” says Dr. Chan. “But our partnership with Cedars-Sinai gives our patients the opportunity to participate in studies for potential new treatments they wouldn’t be able to access otherwise.”

Without Torrance Memorial’s physicians alerting her to Dr. Basho’s study, Enomoto says she wouldn’t have known about the opportunity. Being able to have her treatment take place close to home in Torrance was a big convenience at a difficult time.

“My result was excellent,” Enomoto says. “The treatment essentially killed all the cancer, and without this partnership, I might not have received it.”

Jessie Savolt

Jessie Savolt will celebrate her seventh year with a new heart because the partnership between the Torrance Memorial Lundquist Lurie Cardiovascular Institute and the Smidt Heart Institute at Cedars-Sinai, which was in place before the affiliation, made a transplant possible.

“I’ve just been very fortunate between the two hospitals, with the different doctors who took care of me,” says Savolt. “I’m here because of all of them—all their hard work.”

Terry and Jessie Savolt, Mark, Lurie, MD, and heart failure nurse Roxanna BalterSavolt spent decades battling debilitating fatigue and shortness of breath and two years on the transplant waiting list at another institution. Then in 2015, Torrance Memorial cardiologist Mark Lurie, MD, director of the Lundquist Lurie Cardiovascular Institute, contacted Jon Kobashigawa, MD, director of the heart transplant program at Cedars-Sinai. He was willing to take her on right away in conjunction with colleagues at Torrance Memorial. Within three weeks, Savolt had a heart.

“The teamwork of our integrated heart failure programs, employing ever-evolving medical advances, managed her condition,” says Dr. Lurie. “While heart failure patients are living longer, the time had come to find another option for Jessie.”

Danny Ramzy, MD, vice chair of innovation and director of robotic and minimally invasive cardiac surgery in the Smidt Heart Institute and associate professor of surgery at Cedars-Sinai performed Savolt’s transplant. He says her case was too high-risk for many other medical centers.

“She had two previous heart operations and other issues,” Dr. Ramzy says. “At Cedars-Sinai we have some of the best cardiologists, cardiothoracic surgeons and ICU doctors in the world, and we have an intensive care unit specifically trained for post-transplant management. This allows us to take on these higher-risk patients.”

The affiliation with Torrance Memorial brings these capabilities to patients in and around the South Bay area, Dr. Ramzy says.